Home » Stocks » NRC

National Research Corporation (NRC)

Stock Price: $50.17 USD -1.14 (-2.22%)
Updated December 1, 12:56 PM EST - Market open

Stock Price Chart

Key Info

Market Cap 1.27B
Revenue (ttm) 131.13M
Net Income (ttm) 37.75M
Shares Out 25.30M
EPS (ttm) 1.47
PE Ratio 34.13
Forward PE n/a
Dividend $0.84
Dividend Yield 1.67%

Stock Quote

Trading Day December 1
Last Price $50.17
Previous Close $51.31
Change ($) -1.14
Change (%) -2.22%
Day's Open 51.99
Day's Range 50.11 - 51.99
Day's Volume 16,713
52-Week Range 34.84 - 70.00

More Stats

Market Cap 1.27B
Enterprise Value 1.28B
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 25.30M
Float n/a
EPS (basic) 1.51
EPS (diluted) 1.47
FCF / Share 1.30
Dividend $0.84
Dividend Yield 1.67%
Earnings Yield 2.93%
FCF Yield 2.58%
Payout Ratio 27.80%
Shares Short 171,365
Short Ratio 7.93
Short % of Float n/a
Beta 0.82
PE Ratio 34.13
Forward PE n/a
P/FCF Ratio 38.82
PS Ratio 9.68
PB Ratio 23.84
Revenue 131.13M
Operating Income 44.45M
Net Income 37.75M
Free Cash Flow 32.70M
Net Cash -9.74M
Net Cash / Share -0.38
Gross Margin 62.19%
Operating Margin 33.90%
Profit Margin 28.80%
FCF Margin 24.94%
ROA 22.11%
ROE 88.09%
ROIC 108.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$44.00*
Low
44.0
Current: $50.17
High
44.0
Target: 44.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue12812011810910298.8492.5986.4275.7763.40
Revenue Growth6.93%1.81%7.47%6.88%3.55%6.75%7.14%14.06%19.51%-
Gross Profit81.5572.1168.4963.8157.7357.1253.7550.9647.1038.76
Operating Income43.0435.2834.2231.2026.4528.3024.8122.7218.7413.86
Net Income32.4130.0522.9420.5217.6118.1615.4815.0711.568.50
Shares Outstanding24.8127.0924.2824.2224.2224.2424.1223.7123.3519.91
Earnings Per Share1.261.040.520.480.410.430.370.360.280.42
EPS Growth21.15%100%8.33%17.07%-4.65%16.22%2.78%28.57%-33.33%-
Dividend Per Share0.781.03----0.100.850.290.25
Dividend Growth-24.27%------87.84%189.08%15.81%-
Operating Cash Flow40.9239.8528.0926.8421.8926.2019.3219.1318.4814.60
Capital Expenditures-4.66-5.97-4.57-3.97-2.94-2.49-2.19-2.35-2.81-1.54
Free Cash Flow36.2633.8823.5222.8718.9523.7117.1316.7815.6713.06
Cash & Equivalents13.5212.9934.7333.0242.1540.0422.098.298.083.52
Total Debt34.1737.841.143.625.818.2210.4412.7614.9116.49
Net Cash / Debt-20.66-24.8533.6029.4036.3331.8211.65-4.48-6.83-12.97
Assets11110812712112813011110010195.77
Liabilities77.7988.9537.2837.8253.8341.7639.3343.3045.1247.19
Book Value32.8919.0890.0482.8174.2287.7571.7656.7455.5548.58
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name National Research Corporation
Country United States
Employees 464
CEO Michael D. Hays

Stock Information

Ticker Symbol NRC
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: NRC

Description

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provide actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions; and health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.